Latest filing published 16 Oct 2017 for GlaxoSmithKline plc, €6,763.
Insider track record
No signal scores available.
S Dexter: trading record in brief
S Dexter discloses dealings in GlaxoSmithKline plc to RNS (LSE). Between 20 October 2016 and 12 October 2017, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 October 2017: a share grant of €6,763, in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 4 days after the trade. For comparison, UK MAR gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to S Dexter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 395 shares@ £15.2748London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20171016164252_13398261_20200330131537836_10829
- 460 shares@ £15.7498London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170421144901_13200747_20200330131500661_14441
- 351 shares@ £16.655London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161026154144_013014162_20200330143616705_19648
3 of 3 declarations